Zobrazeno 1 - 10
of 1 066
pro vyhledávání: '"cell immunotherapy"'
Autor:
Hao-Yu Tang, Yi-Zhi Cao, Yi-Wei Zhou, Yu-Shui Ma, Hong Jiang, Hui Zhang, Lin Jiang, Qin-Xin Yang, Xiao-Mei Tang, Chun Yang, Xin-Yun Liu, Fu-Xing Liu, Ji-Bin Liu, Da Fu, Yun-Feng Wang, Hong Yu
Publikováno v:
Journal of Advanced Research, Vol 67, Iss , Pp 253-267 (2025)
Background: Pancreatic cancer, referred to as the “monarch of malignancies,” is a neoplastic growth mostly arising from the epithelial cells of the pancreatic duct and acinar cells. This particular neoplasm has a highly unfavorable prognosis due
Externí odkaz:
https://doaj.org/article/14052595002340848db03e80f1d7f579
Autor:
Aydin Eresen, Zigeng Zhang, Guangbo Yu, Qiaoming Hou, Zhilin Chen, Zeyang Yu, Vahid Yaghmai, Zhuoli Zhang
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Heterogeneity of hepatocellular carcinoma (HCC) presents significant challenges for therapeutic strategies and necessitates combinatorial treatment approaches to counteract suppressive behavior of tumor microenvironment and achiev
Externí odkaz:
https://doaj.org/article/950fad8b8af9492ba6da0a8ed1a941cb
Autor:
Shafieeh Mansoori, Ahmad Noei, Amirhosein Maali, Seyedeh Sheila Seyed-Motahari, Zahra Sharifzadeh
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-22 (2024)
Abstract CAR-T cell therapy is known as an effective therapy in patients with hematological malignancies. Since 2017, several autologous CAR-T cell (auto-CAR-T) drugs have been approved by the US Food and Drug Administration (FDA) for the treatment o
Externí odkaz:
https://doaj.org/article/8699bf73261d447d9122bc152fd6efde
Autor:
Yen-Han Tseng, Ching-Liang Ho, Chih-Feng Chian, Chi-Lu Chiang, Heng-Sheng Chao, Chen-Liang Tsai, Wann-Cherng Perng, Chin-Fu Hsiao, Mei-Hsing Chuang, Kai-Hsiung Ko, Yun-Ching Cheng, Shin-Jung Chen, Chia-Jen Wang, Yuh-Min Chen
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract The 5-year survival is poor for stage IV non-small cell lung cancer (NSCLC). Recently, cell immunotherapy has emerged as a new treatment strategy. This study aimed to evaluate the efficacy and safety of Immune killer cells (IKC) in patients
Externí odkaz:
https://doaj.org/article/60e1e64c9e2f4911833c2dcb19844213
Autor:
Jun Ren, Congcong Li, Dazhao Xu, Kun Wan, Chuxiong Zeng, Lina Hu, Xianzhi Guo, Feifei Huo, Xiumei Rong, Xinna Zhou, Tiecheng Wu, Xiaoli Wang, Bo Sun, JingJing Lou, Amy Hobeika, Michael A. Morse, Herbert Kim Lyerly
Publikováno v:
International Journal of Hyperthermia, Vol 41, Iss 1 (2024)
Purpose Immune checkpoint inhibitors (ICIs) and target therapy have provided the clinical efficacy for improving the clinical progression-free survival (PFS) and overall survival (OS) for patients with renal cell carcinoma (RCC). There has been littl
Externí odkaz:
https://doaj.org/article/bc311b8df66144a488149fa33a320674
Autor:
María-José Felgueres, Gloria Esteso, Álvaro F. García-Jiménez, Ana Dopazo, Nacho Aguiló, Carmen Mestre-Durán, Luis Martínez-Piñeiro, Antonio Pérez-Martínez, Hugh T. Reyburn, Mar Valés-Gómez
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract The short-lived nature and heterogeneity of Natural Killer (NK) cells limit the development of NK cell-based therapies, despite their proven safety and efficacy against cancer. Here, we describe the biological basis, detailed phenotype and f
Externí odkaz:
https://doaj.org/article/bd24417e2d61481aba2a499fb276ab1b
Publikováno v:
Journal of Hepatocellular Carcinoma, Vol Volume 11, Pp 975-995 (2024)
Fahreddin Palaz,1,2 Mehmet Ozsoz,3 Ali Zarrinpar,4,5 Ilyas Sahin5,6 1Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; 2Faculty of Medicine, Hacettepe University, Ankara, Turkey; 3Department of Biomedica
Externí odkaz:
https://doaj.org/article/99a10f975b51442b8d879afdeda046fe
Autor:
Irina Chikileva, Polina Fedorova, Irina Shubina, Stanislav Pshenichnikov, Kateryna Levada, Vyacheslav Abramov, Mikhail Kiselevskiy
Publikováno v:
Exploration of Medicine, Vol 5, Iss 3, Pp 351-362 (2024)
Therapy of malignant tumors still represents a huge problem for healthcare, since these diseases lead to a high rate of disability and premature death of the population. The main problems of adoptive cell therapy for malignant tumors are a low rate o
Externí odkaz:
https://doaj.org/article/a47705bd09c44c13aad86caedc8d2c1c
Publikováno v:
Advanced Science, Vol 11, Iss 36, Pp n/a-n/a (2024)
Abstract Clinical translation of current cancer vaccine research has been hampered by limited antitumor immune responses due to inefficient antigen delivery and presentation, suboptimal DC and T cell activation. Biomaterial‐based nanovaccine offers
Externí odkaz:
https://doaj.org/article/a0d6b6aaab604496b38241737ca8d6b6
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundHigh-risk double-expressor diffuse large B-cell lymphoma has an inferior prognosis following standard first-line therapy. After failure of second-line therapy, treatment options are limited if accompanied by localized compressive symptoms.
Externí odkaz:
https://doaj.org/article/f361748b4c4a46c0a963f0350bb8c9e8